LFCR (Lifecore Biomedical) Institutional Ownership: 71.42% (As of Jul. 13, 2026)


LFCR Lifecore Biomedical Inc LFCR
55 GF Score
Price $4.77
GF Value $6.48
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Lifecore Biomedical Institutional Ownership?

Lifecore Biomedical LFCR +0.21% 55 Institutional Ownership is 71.42% as of Jul. 13, 2026. GuruFocus rates LFCR with a GF Score™ of 55/100 and a GF Value™ of $6.48 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lifecore Biomedical's institutional ownership is 71.42%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lifecore Biomedical's Insider Ownership is 10.87%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lifecore Biomedical's Float Percentage Of Total Shares Outstanding is 81.28%.


Lifecore Biomedical Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Lifecore Biomedical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical Institutional Ownership Chart

Lifecore Biomedical Historical Data

The historical data trend for Lifecore Biomedical can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 16.88 15.59 15.95 16.28 16.10 16.15 15.85 15.55 15.58 16.02
LFCR
55GF Score
Lifecore Biomedical Inc LFCR
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lifecore Biomedical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 71.42% mean?
Lifecore Biomedical (LFCR) has a Institutional Ownership of 71.42% as of Jul. 13, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Lifecore Biomedical and its competitors.
Is Lifecore Biomedical's Institutional Ownership too high?
Lifecore Biomedical's current Institutional Ownership is 71.42%. Overall, Lifecore Biomedical has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lifecore Biomedical's Institutional Ownership compare to ANIK and DERM?
Lifecore Biomedical's Institutional Ownership of 71.42% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Lifecore Biomedical and its competitors. Lifecore Biomedical's current Institutional Ownership is 71.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecore Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Lifecore Biomedical (LFCR) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.48, compared to a current price of $4.77 — trading 26.5% below its estimated fair value. The current Institutional Ownership is 71.42%. Lifecore Biomedical's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Lifecore Biomedical (LFCR), the current Institutional Ownership is 71.42% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifecore Biomedical (LFCR) Overvalued in 2026?

Based on GuruFocus' analysis, Lifecore Biomedical stock appears to be undervalued. The current stock price of $4.77 is trading 26.5% below its estimated GF Value™ of $6.48. GuruFocus considers Lifecore Biomedical to be Modestly Undervalued.

Key valuation signals for LFCR:

  • Institutional Ownership: 71.42%
  • GF Value™: $6.48 vs. price of $4.77 (26.5% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the LFCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lifecore Biomedical Business Description

Other Exchanges LDE:Germany
Address 3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
55GF Score

Get the complete analysis for LFCR

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.77
Price
$6.48
GF Value